Intra Cellular Therapies shares owned by Credit Suisse
Quarter-by-quarter ownership of Intra Cellular Therapies (ITCI) shares owned by Credit Suisse
from 13F filings
Historical chart of Credit Suisse investment in Intra Cellular Therapies
Tip: Access up to 7 years of quarterly data
All positions including Intra Cellular Therapies held by Credit Suisse consolidated in one spreadsheet with up to 7 years of data
Download as csv
Download as Excel
Quarterly reported holdings in Intra Cellular Therapies by Credit Suisse
| Quarter filed | Position value | Share count | Share price at filing |
|---|---|---|---|
| 2023-12-31 | $8.5M | 119k | 71.62 |
| 2023-09-30 | $5.8M | 112k | 52.09 |
| 2023-06-30 | $7.4M | 116k | 63.32 |
| 2023-03-31 | $5.9M | 109k | 54.15 |
| 2022-12-31 | $5.6M | 105k | 52.92 |
| 2022-09-30 | $3.6M | 77k | 46.51 |
| 2022-06-30 | $4.2M | 74k | 57.10 |
| 2022-03-31 | $4.5M | 74k | 61.16 |
| 2021-12-31 | $3.0M | 57k | 52.30 |
| 2021-09-30 | $11M | 301k | 37.28 |
| 2021-06-30 | $1.9M | 48k | 40.78 |
| 2021-03-31 | $2.7M | 52k | 52.63 |
| 2020-12-31 | $2.8M | 89k | 31.80 |
| 2020-09-30 | $1.2M | 55k | 22.73 |
| 2020-06-30 | $1.6M | 61k | 25.67 |
| 2020-03-31 | $2.2M | 146k | 15.37 |
| 2019-12-31 | $849k | 25k | 34.22 |
| 2019-09-30 | $247k | 33k | 7.45 |
| 2019-06-30 | $261k | 22k | 11.76 |
| 2019-03-31 | $323k | 23k | 14.08 |
| 2018-12-31 | $256k | 23k | 11.41 |
| 2018-09-30 | $475k | 22k | 21.70 |
| 2018-06-30 | $541k | 31k | 17.63 |
| 2018-03-31 | $0 | 36k | 0.00 |
| 2017-12-31 | $580k | 40k | 14.59 |
| 2017-09-30 | $613k | 39k | 15.81 |
| 2017-06-30 | $0 | 18k | 0.00 |
| 2017-03-31 | $341k | 21k | 16.28 |
| 2016-12-31 | $0 | 37k | 0.00 |
| 2016-09-30 | $427k | 28k | 15.26 |
| 2016-06-30 | $1.0M | 27k | 38.84 |
| 2016-03-31 | $696k | 25k | 27.70 |
| 2015-12-31 | $588k | 11k | 55.56 |
| 2015-09-30 | $612k | 15k | 40.02 |
| 2015-06-30 | $417k | 13k | 31.79 |
| 2015-03-31 | $1.1M | 48k | 23.87 |
| 2014-06-30 | $344k | 20k | 16.85 |
| 2014-03-31 | $660k | 36k | 18.18 |